Expression of nestin in ovarian serous cancer and its clinicopathologic significance

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 21, 2013, Pages 2896-2901

  He, Q Z ^a   Luo, X Z ^b   Zhou, Q ^a   Wang, K ^a   Li, S X ^a   Li, Y ^a   Zhu, H T ^a   Duan, Tony ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b OBSTETRICS AND GYNECOLOGY HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Nestin; Serous ovarian carcinoma; Stem cell marker

Indexed keywords

CA 125 ANTIGEN; NESTIN; PACLITAXEL; PLATINUM DERIVATIVE;

ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PATIENT; CANCER RESISTANCE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY ADENOCARCINOMA; OVARY CARCINOMA; PROTEIN EXPRESSION; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; CA-125 ANTIGEN; CYSTADENOCARCINOMA, SEROUS; DISEASE PROGRESSION; DRUG RESISTANCE, NEOPLASM; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NESTIN; OVARIAN NEOPLASMS; OVARY;

EID: 84891767276     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. JEMAL A, CENTER MM, WARD E, THUN MJ. Cancer occurrence. Methods Mol Biol 2009; 471: 3-29.
2. COLEMAN RL, MONK BJ, SOOD AK, HERZOG TJ. Latest research and treatment of advanced-stage epithelial ovarian cancer. Nat Rev Clin Oncol 2013; 10: 211-224.
3. AHMED N, ABUBAKER K, FINDLAY J, QUINN M. Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance. J Cell Biochem 2013; 114: 21-34.
4. LI H, CHERUKURI P, LI N, COWLING V, SPINELLA M, COLE M, GODWIN AK, WELLS W, DIRENZO J. Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors. Cancer Res 2007; 67: 501-510.
5. RYUGE S, SATO Y, WANG GQ, MATSUMOTO T, JIANG SX, KATONO K, INOUE H, SATOH Y, MASUDA N. Prognostic significance of nestin expression in resected non-small cell lung cancer. Chest 2011; 139: 862-869.
6. SINGH SK, CLARKE ID, HIDE T, DIRKS PB. Cancer stem cells in nervous system tumors. Oncogene 2004; 23: 7267-7273.
7. OKUNO K, OHTA S, KATO H, TAGA T, SUGITA K, TAKEUCHI Y. Expression of neural stem cell markers in malignant rhabdoid tumor cell lines. Oncol Rep 2010; 23: 485-492.
8. KASPER S. Exploring the origins of the normal prostate and prostate cancer stem cell. Stem Cell Rev 2008; 4: 193-201.
9. RAMALHO-SANTOS M, YOON S, MATSUZAKI Y, MULLIGAN RC, MELTON DA. "Stemness": Transcriptional profiling of embryonic and adult stem cells. Science 2002; 298: 597-600.
10. KRUPKOVA O JR, LOJA T, REDOVA M, NERADIL J, ZITTERBART K, STERBA J, VESELSKA R. Analysis of nuclear nestin localization in cell lines derived from neurogenic tumors. Tumour Biol 2011; 32: 631-639.
11. NESS RB, COTTREAU C. Possible role of ovarian epithelial inflammation in ovarian cancer. J Natl Cancer Inst 1999; 91: 1459-1467.
12. CANNISTRA SA. Cancer of the ovary. N Engl J Med 2004; 351: 2519-2529.
13. BAPAT SA, MALI AM, KOPPIKAR CB, KURREY NK. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 2005; 65: 3025-3029.
14. ZHANG S, BALCH C, CHAN MW, LAI HC, MATEI D, SCHILDER JM, YAN PS, HUANG TH, NEPHEW KP. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 2008; 68: 4311-4320.